1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Masitinib (6.0): new trials by email Literature Review of Masitinib (6.0) trials Research Report on Masitinib (6.0)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients Masitinib (6.0), Riluzole, Placebo - Amyotrophic Lateral Sclerosis | Phase 3 | Recruiting | AB Science | 495 | 2021-02-02 | 2025-09-12 |
Amyotrophic Lateral Sclerosis (1) · Motor Neuron Disease (1)
AB Science (1)
Belgium (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Norway (1) · Poland (1) · Portugal (1) · Russia (1) · Serbia (1) · Slovenia (1) · Spain (1) · Sweden (1)